A long (7 cm) prophylactic pancreatic stent decreases incidence of post-endoscopic papillectomy pancreatitis: a retrospective study

Abstract

Background and study aims Endoscopic papillectomy (EP) is a minimally invasive treatment for ampullary neoplasms and is recognized as an alternative treatment to surgical resection; however, there are few reports on a suitable pancreatic stent (PS) after EP for preventing pancreatitis. The aim of this study was to evaluate the efficacy of a long PS after EP.

Patients and methods In this retrospective single-center study, 39 patients with pathologically proven ampullary neoplasms who underwent EP between March 2012 and August 2018 were enrolled. The study participants were divided into two subgroups according to the PS length: those with a PS shorter than 5 cm (short PS group, n = 17) and those with a PS of 7 cm (long PS group, n = 22). The incidence of adverse events and risk factors for pancreatitis were evaluated.

Results The diameter of all PSs was 5 Fr. Post-EP pancreatitis occurred in nine patients (23.1 %), with two cases of severe pancreatitis (5.1 %). Pancreatitis occurred more frequently in the short PS group (7/17, 41.2 %) than in the long PS group (2/22, 9.1 %) (P = 0.026). There were no significant differences between the two groups in terms of other adverse events. Univariate and multivariate analyses showed that a long PS was the only factor associated with a decreased incidence of post-EP pancreatitis (P = 0.042; odds ratio, 0.16; 95 % confidence interval, 0.027–0.94).

Conclusion A long (7 cm) PS significantly decreased incidence of pancreatitis after EP. Prospective randomized studies with a larger number of patients and wider range of PS lengths are required.

• References

• 1 Suzuki K, Kantou U, Murakami Y. Two cases with ampullary cancer who underwent endoscopic excision. Prog Dig Endosc 1983; 23: 236239
• 2 Catalano MF, Linder JD, Chak A. et al. Endoscopic management of adenoma of the major duodenal papilla. Gastrointest Endosc 2004; 59: 225-232
• 3 Bohnacker S, Seitz U, Nguyen D. et al. Endoscopic resection of benign tumors of the duodenal papilla without and with intraductal growth. Gastrointest Endosc 2005; 62: 551-560
• 4 Cheng CL, Sherman S, Fogel EL. et al. Endoscopic snare papillectomy for tumors of the duodenal papillae. Gastrointest Endosc 2004; 60: 757-764
• 5 Stolte M, Pscherer C. Adenoma-carcinoma sequence in the papilla of Vater. Scand J Gastroenterol 1996; 31: 376-382
• 6 Yamaguchi K, Enjoji M. Carcinoma of the ampulla of Vater. A clinicopathologic study and pathologic staging of 109 cases of carcinoma and 5 cases of adenoma. Cancer 1987; 59: 506-515
• 7 Heinzow HS, Lenz P, Lenze F. et al. Feasibility of snare papillectomy in ampulla of Vater tumors: Meta-analysis and study results from a tertiary referral center. Hepatogastroenterol 2012; 59: 332-335
• 8 Ardengh JC, Kemp R, Lima-Filho ER. et al. Endoscopic papillectomy: The limits of the indication, technique and results. World J Gastrointest Endosc 2015; 7: 987-994
• 9 Napoleon B, Alvarez-Sanchez MV, Leclercq P. et al. Systematic pancreatic stenting after endoscopic snare papillectomy may reduce the risk of postinterventional pancreatitis. Surg Endosc 2013; 27: 3377-3387
• 10 Ito K, Fujita N, Noda Y. et al. Impact of technical modification of endoscopic papillectomy for ampullary neoplasm on the occurrence of complications. Dig Endosc 2012; 24: 30-35
• 11 Itoi T, Tsuji S, Sofuni A. et al. A novel approach emphasizing preoperative margin enhancement of tumor of the major duodenal papilla with narrow-band imaging in comparison to indigo carmine chromoendoscopy (with videos). Gastrointest Endosc 2009; 69: 136-141
• 12 Lee TY, Cheon YK, Shim CS. et al. Endoscopic wire-guided papillectomy versus conventional papillectomy for ampullary tumors: A prospective comparative pilot study. J Gastroenterol Hepatol 2016; 31: 897-902
• 13 Hyun JJ, Lee TH, Park JS. et al. A prospective multicenter study of submucosal injection to improve endoscopic snare papillectomy for ampullary adenoma. Gastrointest Endosc 2017; 85: 746-755
• 14 Choudhary A, Bechtold ML, Arif M. et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: A meta-analysis and systematic review. Gastrointest Endosc 2011; 73: 275-282
• 15 Sofuni A, Maguchi H, Itoi T. et al. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin Gastroenterol Hepatol 2007; 5: 1339-1346
• 16 Napoleon B, Gincul R, Ponchon T. et al. Endoscopic papillectomy for early ampullary tumors: Long-term results from a large multicenter prospective study. Endoscopy 2014; 46: 127-134
• 17 Harewood GC, Pochron NL, Gostout CJ. Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla. Gastrointest Endosc 2005; 62: 367-370
• 18 Afghani E, Akshintala VS, Khashab MA. et al. 5-Fr vs. 3-Fr pancreatic stents for the prevention of post-ERCP pancreatitis in high-risk patients: A systematic review and network meta-analysis. Endoscopy 2014; 46: 573-580
• 19 Olsson G, Lubbe J, Arnelo U. et al. The impact of prophylactic pancreatic stenting on post-ERCP pancreatitis: A nationwide, register-based study. United European Gastroenterol J 2017; 5: 111-118
• 20 Ito K, Fujita N, Kanno A. et al. Risk factors for post-ERCP pancreatitis in high risk patients who have undergone prophylactic pancreatic duct stenting: A multicenter retrospective study. Intern Med 2011; 50: 2927-2932
• 21 Chandrasekhara V, Khashab MA. et al. ASGE Standards of Practice Committee. Adverse events associated with ERCP. Gastrointest Endosc 2017; 85: 32-47
• 22 Tsuji S, Itoi T, Sofuni A. et al. Tips and tricks in endoscopic papillectomy of ampullary tumors: Single-center experience with large case series (with videos). J Hepatobiliary Pancreat Sci 2015; 22: E22-E27
• 23 Cotton PB, Lehman G, Vennes J. et al. Endoscopic sphincterotomy complications and their management: An attempt at consensus. Gastrointest Endosc 1991; 37: 383-393
• 24 Zhang C, Yang YL, Ma YF. et al. The modified pancreatic stent system for prevention of post-ERCP pancreatitis: A case-control study. BMC Gastroenterol 2017; 17: 108
• 25 Johanson JF, Schmalz MJ, Geenen JE. Incidence and risk factors for biliary and pancreatic stent migration. Gastrointest Endosc 1992; 38: 341-346
• 26 Mazaki T, Masuda H, Takayama T. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: A systematic review and meta-analysis. Endoscopy 2010; 42: 842-853
• 27 Topazian M, Baron TH, Fidler JL. et al. Endoscopic retrieval of a migrated pancreatic stent from the retroperitoneum. Gastrointest Endosc 2008; 67: 728-729
• 28 Zapatier JA, Jani P, Pimentel R. et al. Pancreatic stent migration into the bile duct causing cholangitis. Endoscopy 2013; 45 (Suppl. 02) E324-E325
• 29 Leung WD, Parashette KR, Molleston JP. et al. Pancreatic stent migration into the portal vein causing portal vein thrombosis: A rare complication of a prophylactic pancreatic stent. Pancreatology 2012; 12: 463-465
• 30 Pelz J, Farnbacher MJ, Raithel M. et al. Perforation of the splenic artery as a complication of endoscopic pancreatic stent placement in chronic obstructing pancreatitis. Endoscopy 2013; 45 (Suppl. 02) E203-E204
• 31 Kubota K, Fujita Y, Sato T. et al. Tumor diameter and Ki-67 expression in biopsy could be diagnostic markers discriminating from adenoma and early stage cancer in patients with ampullary tumors. J Hepatobiliary Pancreat Sci 2013; 20: 531-537